Safe and acceptable strategies for producing foreign molecules in plants

Current Opinion in Plant Biology

Volumn 7, Issue 2, 2004, Pages 189-195

  Mascia, Peter N ^a   Flavell, Richard B ^a  

^a Ceres Inc   (United States)

Author keywords

Animal and Public Health Information System; APHIS; Industrial or pharmaceutical products; IPP; PHA; Polyhydroxyalkanoate; UAS; Upstream activating sequence; US Department of Agriculture; USDA

Indexed keywords

BIOTECHNOLOGY; GENETICS; METABOLISM; METHODOLOGY; REVIEW; SAFETY; TRANSGENE; TRANSGENIC PLANT;

BIOTECHNOLOGY; PLANTS, GENETICALLY MODIFIED; SAFETY MANAGEMENT; TRANSGENES;

ANIMALIA;

EID: 1542351252     PISSN: 13695266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbi.2004.01.014     Document Type: Review

References (49)

1. Raskin I., Ribnicky D.M., Komarnytsky S., Ilis N., Poulev A., Borisuk N., Brinker A., Moreno D.A., Ripoll C., Yakoby N.et al. Plants and human health in the twenty-first century. Trends Biotechnol. 20:2002;522-531 The authors discuss the rediscovery of the use of plants for medicinal, food and dietary supplement applications. They provide an exhaustive list of plant-derived pharmaceuticals and dietary supplements as well as a list of proteins under consideration for production in plants. They suggest that plants are "poised for a comeback" as sources of a variety of medicinal products.
2. Ma J.K., Drake P.M.W., Christou P. The production of recombinant pharmaceutical proteins in plants. Nature Reviews. 4:2003;795-905 The authors review the benefits of recombinant protein production in plants. They provide a detailed list of the proteins being produced in plants and some of the safety issues that are associated with production of proteins in plants.
3. Daniell H. GM crops: public perception and scientific solutions. Trends Plant Sci. 4:1999;467-469.
4. Fischer R., Emans N. Molecular farming of pharmaceutical proteins. Transgenic Res. 9:2000;279-299.
5. Korban S.S., Krasnyanski S.F., Buetow D.E. Foods as production and delivery vehicles for human vaccines. J Am Coll Nutr. 21:2002;212S-217S.
6. Gura T. New ways to glean medicines from plants. Science. 285:1999;1347-1349.
7. Kong Q., Richter L., Yang Y.F., Arntzen C.J., Mason H.S., Thanavala Y. Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci USA. 98:2001;11539-11544.
8. Gura T. The battlefields of Britain. Nature. 412:2001;760-763.
9. Adam D. Hostilities resume over future of GM crops. Nature. 419:2002;327.
10. Fox J.L. Agbiotech issues climb US political agenda. Nat Biotechnol. 20:2002;1179-1180.
11. Giles J. Biosafety trials darken outlook for transgenic crops in Europe. Nature. 425:2003;751.
12. Knight J. Trade war looms as US launches challenge over transgenic crops. Nature. 423:2003;369.
13. Kapuscinski A.R., Goodman R.M., Hann S.D., Jacobs L.R., Pullins E.E., Johnson C.S., Kinsey J.D., Krall R.L., LaViña A.G.M., Mellon M.G., Ruttan V.W. Making 'safety first' a reality for biotechnology products. Nat Biotechnol. 21:2003;599-601.
14. Arntzen C.J., Cochlan A., Johnson B., Peacock J., Rodemeyer M. GM crops: science, politics and communication. Nature Rev Genet. 4:2003;839-843 A thoughtful and insightful discussion by several leading experts on GMO issues. The authors call for effective regulatory science as well as effective communication with consumers.
15. Vasil I.K. The science and politics of plant biotechnology - a personal perspective. Nat Biotechnol. 21:2003;849-851.
16. Strauss S.H. Genomics, genetic engineering, and domestication of crops. Science. 300:2003;61-62.
17. Fox J.L. EPA re-evaluates StarLink license. Nat Biotechnol. 19:2001;11.
18. Fox J. USDA, EPA remove StarLink corn from feed. Nat Biotechnol. 19:2001;298.
19. Dorey E. Taco dispute underscores need for standardized tests. Nat Biotechnol. 18:2000;1136-1137.
20. Kaiser J. Toxicology. Panel urges further study of biotech corn. Science. 290:2000;1867.
21. Wadman M. US processor rejects maize EU won't take. Nature. 398:1999;736.
22. USDA to purchase cry9c affected corn seed from small seed companies. USDA press release, March 7, 2001.
23. USDA announces actions regarding plant protection act violations involving ProdiGene, Inc. USDA press release, December 6, 2002.
24. USDA investigates biotech company for possible permit violations. USDA press release, November 13, 2002.
25. Fox J.L. Puzzling industry response to ProdiGene fiasco. Nat Biotechnol. 21:2003;3-4.
26. Anon: Permitting Genetically Engineered Plants That Produce Pharmaceutical Compounds. USDA Factsheet. September 2002.
27. Anon: Guidance for industry drugs, biologics, and medical devices derived from bioengineered plants for use in humans and animals, draft guidance. Docket No. 02D-0324, CBER 200134; Federal Register 2002, 67:57828-57829.
28. Anon: Field testing of plants engineered to produce pharmaceutical and industrial compounds. Docket No. 03-031-1, 7 CFR Part 340; Federal Register 2003, 68:11337-11340.
29. Anon: Introductions of plants genetically engineered to produce industrial compounds. Docket No. 03-038-1, 7 CFR Part 340; Federal Register 2003, 68:46434-46436.
30. Kochenderfer K: Re: Docket No. 03-031-1 GMA Comments on USDA Bio-Pharma Permit Regulations 03/10/2003. Field Testing of Plants Engineered To Produce Pharmaceutical and Industrial Compounds. Grocery Manufacturers of America, 2003. ( http://www.gmabrands.org/publicpolicy/docs/Comment.cfm?DocID=1135& ).
31. Howell S. From the director. Plant Sciences Institute Update. 2:2002;2.
32. Commandeur U., Twyman R.M., Fischer R. The biosafety of molecular farming in plants. AgDiotechNet. 5:2003;1-9 The authors focus on biosafety concerns relating to the production of industrial or pharmaceutical products in plants. They review the concept of environmental pollution and contamination of the food supply with transgenes and proteins.
33. Anon: High-tech tomatoes get luxury residence. Nature 2003, 421:882.
34. Service R.F. Seed-sterilizing 'terminator technology' sows discord. Science. 282:1998;850-851.
35. Kaiser J. USDA to commercialize 'terminator' technology. Science. 289:2000;709-710.
36. Bushell C., Spielman M., Scott R.J. The basis of natural and artificial postzygotic hybridization barriers in Arabidopsis species. Plant Cell. 15:2003;1430-1442.
37. Kiegle E., Moore C.A., Haseloff J., Tester M.A., Knight M.R. Cell-type-specific calcium responses to drought, salt and cold in the Arabidopsis root. Plant J. 23:2000;267-278.
38. Pfeifer K., Kim K.S., Kogan S., Guarente L. Functional dissection and sequence of yeast HAP1 activator. Cell. 56:1989;291-301.
39. Stone S.L., Kwong L.W., Yee K.M., Pelletier J., Lepiniec L., Fischer R.L., Goldberg R.B., Harada J.J. Leafy cotyledon 2 encodes a B3 domain transcription factor that induces embryo development. Proc Natl Acad Sci USA. 98:2001;11806-11811.
40. Wu C.Y., Suzuki A., Washida H., Takaiwa F. The GCN4 motif in a rice glutin gene is essential for endosperm-specific gene expression and is activated by Opaque-2 in transgenic rice plants. Plant J. 14:1998;673-683.
41. Van Ooijen AJJ, Rietveld K, Hoekema A, Pen J, Sijmons PC, Verwoerd TC, Quax WJ: Production of enzymes in seeds and their use. 6 August, 1996; US Patent 5,543,576. Syngenta ( www.syngenta.com ).
42. Hiatt AC, Hein MB: Compositions containing glycopolypeptide multimers and methods of making same in plants. 17 June, 1997; US Patent 5,639,947. Epicyte ( www.epicyte.com ).
43. Bright SWJ, Byrom D, Fentem PA: Production of polyhydroxy alkanoate in plants. 26 March, 1996; US Patent 5,502,273. Syngenta ( www.syngenta.com ).
44. Curtiss R, Cardineau GA: Oral immunization by transgenic plants. 5 August, 1997; US Patent 5,654,184. Dow ( www.dow.com ).
45. Arntzen CJ, Lam DM: Vaccines expressed in plants. 24 October, 2000; US Patent 6,136,320. Prodigene ( www.prodigene.com ).
46. Caimi PG, Hershey HP, Kerr PS: Accumulation of fructans in plants by targeted expression of bacterial levansucrase. 1999; US Patent 5,908,975. DuPont ( www.dupont.com ).
47. Heyer AG, Wendenburg R: Process for producing transgenic inulin-generating plants. 2001; US Patent 6,255,562. KWS SAAT AG ( www.kws.de ).
48. Oliver MJ, Quisenberry JE, Trolinder NLG, Keim DL: Control of plant gene expression. US patent 1998, 5,723,765.
49. Donson J, Dawson WO, Granthan GL, Turpen TH, Turpen AM, Garger SJ, Grill LK: Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes. 31 May, 1994; US patent 5,316,931. Large Scale Biology ( www.lsbc.com ).